跳到正文
Cell Reports Medicine· Kerryan Ashley, Alicia Ding, Mohammad Arammash, Krishna Iyer, Kishu Ranjan, Barani Kumar Rajendran, Boyu Huang, Daniel Boiarsky, Roy Herbst, Sarah Goldberg, Kurt A. Schalper·· 10 天前AI 评分40

促炎状态上调人非小细胞肺癌CD39/CD73腺苷能通路,放化疗可改变其表达

The CD39/CD73 adenosinergic pathway is increased by proinflammatory states and modified by chemo-radiation in human non-small cell lung cancer

AI 导读

Ashley等报告,产腺苷酶CD39和CD73在超过85%的非小细胞肺癌(NSCLC)中呈诱导性、炎症驱动的免疫抑制通路表达。该通路在肿瘤浸润淋巴细胞(TIL)和PD-L1升高或缺乏STK11/KEAP1突变的肺腺癌中优先表达,并可被放化疗抑制。

来源:Cell Reports Medicine · cell.com